Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-26-030243
Filing Date
2026-03-18
Accepted
2026-03-18 11:07:06
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm268906-3_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm268906-3_3seq1.xml 3 3965
  Complete submission text file 0001104659-26-030243.txt   5375
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Issuer) CIK: 0001574232 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address CHEMIN DES MINES 9 CH-1202 GENEVA V8 CH-1202
Business Address
Dyer Timothy Mark (Reporting) CIK: 0001830908 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39179 | Film No.: 26766813